The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
Open accessAbstract
The cardiovascular effects of epoxyeicosatrienoic acids (EETs) include vasodilation, antimigratory actions on vascular smooth muscle cells and anti-inflammatory actions. These endogenous lipid mediators are broken down into diols by soluble epoxide hydrolase (sEH), and so inhibiting this enzyme would be expected to enhance the beneficial cardiovascular properties of EETs. sEH inhibitors (sEHIs) that are based on 1,3-disubstituted urea have been rapidly developed, and have been shown to be antihypertensive and anti-inflammatory, and to protect the brain, heart and kidney from damage. Although challenges for the future exist — including improving the drug-like properties of sEHIs and finding better ways to target sEHIs to specific tissues — the recent initiation of the first clinical trials of sEHIs has highlighted the therapeutic potential of these agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function
Roman, R. J. (2002) · Physiological Reviews · doi:10.1152/physrev.00021.2001 · Cited by 1,309
Identification of Epoxyeicosatrienoic Acids as Endothelium-Derived Hyperpolarizing Factors
Campbell, W. B., Gebremedhin, D., Pratt, P. F., & Harder, D. R. (1996) · Circulation Research · doi:10.1161/01.res.78.3.415 · Cited by 1,221
Anti-inflammatory Properties of Cytochrome P450 Epoxygenase-Derived Eicosanoids
Node, K., Huo, Y., Ruan, X., Yang, B., Spiecker, M., Ley, K., Zeldin, D. C., & Liao, J. K. (1999) · Science · doi:10.1126/science.285.5431.1276 · Cited by 1,215
Grosser, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27291 · Cited by 1,027
Prostanoid Receptors: Subtypes and Signaling
Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.661 · Cited by 1,011
Cytochrome P450 2C is an EDHF synthase in coronary arteries
Fisslthaler, B., Popp, R., Kiss, L., Potente, M., Harder, D. R., Fleming, I., & Busse, R. (1999) · Nature · doi:10.1038/46816 · Cited by 911
Coxibs and Cardiovascular Disease
FitzGerald, G. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048288 · Cited by 899
Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function
Spector, A. A., Fang, X., Snyder, G. D., & Weintraub, N. L. (2004) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00049-3 · Cited by 589
EPOXIDE HYDROLASES: Mechanisms, Inhibitor Designs, and Biological Roles
Morisseau, C., & Hammock, B. D. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095920 · Cited by 479
Self-citationAction of epoxyeicosatrienoic acids on cellular function
Spector, A. A., & Norris, A. W. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00402.2006 · Cited by 477
Epoxide hydrolases: their roles and interactions with lipid metabolism
Newman, J. W., Morisseau, C., & Hammock, B. D. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2004.10.001 · Cited by 474
Self-citationSoluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic Acids
Yu, Z., Xu, F., Huse, L. M., Morisseau, C., Draper, A. J., Newman, J. W., Parker, C., Graham, L., Engler, M. M., Hammock, B. D., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.11.992 · Cited by 467
Self-citationEnd-Stage Renal Disease in the United States: An Update from the United States Renal Data System
Foley, R. N., & Collins, A. J. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007020220 · Cited by 459
Soluble epoxide hydrolase is a therapeutic target for acute inflammation
Schmelzer, K. R., Kubala, L., Newman, J. W., Kim, I.-H., Eiserich, J. P., & Hammock, B. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503279102 · Cited by 441
Self-citationArachidonic acid cytochrome P450 epoxygenase pathway
Spector, A. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800038-jlr200 · Cited by 413
Soluble Epoxide Hydrolase Inhibition Lowers Arterial Blood Pressure in Angiotensin II Hypertension
Imig, J. D., Zhao, X., Capdevila, J. H., Morisseau, C., & Hammock, B. D. (2002) · Hypertension · doi:10.1161/hy0202.103788 · Cited by 400
Self-citationTargeted Disruption of Soluble Epoxide Hydrolase Reveals a Role in Blood Pressure Regulation
Sinal, C. J., Miyata, M., Tohkin, M., Nagata, K., Bend, J. R., & Gonzalez, F. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m008106200 · Cited by 341
Liu, Y., Zhang, Y., Schmelzer, K., Lee, T.-S., Fang, X., Zhu, Y., Spector, A. A., Gill, S., Morisseau, C., Hammock, B. D., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508081102 · Cited by 300
Self-citationJiang, J.-G., Chen, C.-L., Card, J. W., Yang, S., Chen, J.-X., Fu, X.-N., Ning, Y.-G., Xiao, X., Zeldin, D. C., & Wang, D. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4173 · Cited by 284
Seubert, J., Yang, B., Bradbury, J. A., Graves, J., Degraff, L. M., Gabel, S., Gooch, R., Foley, J., Newman, J., Mao, L., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000139436.89654.c8 · Cited by 273
Self-citationArcher, S. L., Gragasin, F. S., Wu, X., Wang, S., McMurtry, S., Kim, D. H., Platonov, M., Koshal, A., Hashimoto, K., Campbell, W. B., et al. (2003) · Circulation · doi:10.1161/01.cir.0000047278.28407.c2 · Cited by 265
Imig, J. D., Zhao, X., Zaharis, C. Z., Olearczyk, J. J., Pollock, D. M., Newman, J. W., Kim, I.-H., Watanabe, T., & Hammock, B. D. (2005) · Hypertension · doi:10.1161/01.hyp.0000176237.74820.75 · Cited by 257
Self-citationDistribution of Soluble Epoxide Hydrolase and of Cytochrome P450 2C8, 2C9, and 2J2 in Human Tissues
Enayetallah, A. E., French, R. A., Thibodeau, M. S., & Grant, D. F. (2004) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540405200403 · Cited by 255
Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle
Gebremedhin, D., Ma, Y. H., Falck, J. R., Roman, R. J., VanRollins, M., & Harder, D. R. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.263.2.h519 · Cited by 253
Physiological Regulation of Prostaglandins in the Kidney
Hao, C.-M., & Breyer, M. D. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100614 · Cited by 247
Spiecker, M., Darius, H., Hankeln, T., Soufi, M., Sattler, A. M., Schaefer, J. R., Node, K., Börgel, J., Mügge, A., Lindpaintner, K., et al. (2004) · Circulation · doi:10.1161/01.cir.0000143832.91812.60 · Cited by 240
Node, K., Ruan, X.-L., Dai, J., Yang, S.-X., Graham, L., Zeldin, D. C., & Liao, J. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100439200 · Cited by 234
Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors
Xu, D., Li, N., He, Y., Timofeyev, V., Lu, L., Tsai, H.-J., Kim, I.-H., Tuteja, D., Mateo, R. K. P., Singapuri, A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609158103 · Cited by 233
Self-citationEpoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases
Imig, J. D. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00350.2004 · Cited by 233
Self-citationOrally Bioavailable Potent Soluble Epoxide Hydrolase Inhibitors
Hwang, S. H., Tsai, H.-J., Liu, J.-Y., Morisseau, C., & Hammock, B. D. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070270t · Cited by 225
Self-citationSoluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage.
Zhao, X., Yamamoto, T., Newman, J. W. I., Kim, I.-H., Watanabe, T., Hammock, B. D., Stewart, J. P., Pollock, J. S., Pollock, D. M., & Imig, J. D. (2004) · PubMed · Cited by 222
Self-citationNewman, J. W., Morisseau, C., Harris, T. R., & Hammock, B. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437724100 · Cited by 219
Self-citationTraditional and emerging cardiovascular risk factors in end-stage renal disease
Zoccali, C., Mallamaci, F., & Tripepi, G. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s85.25.x · Cited by 206
Role of Soluble Epoxide Hydrolase in Postischemic Recovery of Heart Contractile Function
Seubert, J. M., Sinal, C. J., Graves, J., DeGraff, L. M., Bradbury, J. A., Lee, C. R., Goralski, K., Carey, M. A., Luria, A., Newman, J. W., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000237390.92932.37 · Cited by 195
Self-citationLee, C. R., North, K. E., Bray, M. S., Fornage, M., Seubert, J. M., Newman, J. W., Hammock, B. D., Couper, D. J., Heiss, G., & Zeldin, D. C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl085 · Cited by 193
Self-citationSchmelzer, K. R., Inceoglu, B., Kubala, L., Kim, I.-H., Jinks, S. L., Eiserich, J. P., & Hammock, B. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605908103 · Cited by 189
Self-citationSoluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways
Inceoglu, B., Jinks, S. L., Ulu, A., Hegedus, C. M., Georgi, K., Schmelzer, K. R., Wagner, K., Jones, P. D., Morisseau, C., & Hammock, B. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809765105 · Cited by 187
Self-citationSoluble Epoxide Hydrolase Is a Main Effector of Angiotensin II–Induced Hypertension
Jung, O., Brandes, R. P., Kim, I.-H., Schweda, F., Schmidt, R., Hammock, B. D., Busse, R., & Fleming, I. (2005) · Hypertension · doi:10.1161/01.hyp.0000153792.29478.1d · Cited by 180
Self-citationPozzi, A., Macias-Perez, I., Abair, T., Wei, S., Su, Y., Zent, R., Falck, J. R., & Capdevila, J. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501730200 · Cited by 178
Ishizuka, T., Cheng, J., Singh, H., Vitto, M. D., Manthati, V. L., Falck, J. R., & Laniado-Schwartzman, M. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.130336 · Cited by 177
Larsen, B. T., Miura, H., Hatoum, O. A., Campbell, W. B., Hammock, B. D., Zeldin, D. C., Falck, J. R., & Gutterman, D. D. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00927.2005 · Cited by 172
Self-citationSun, J., Sui, X., Bradbury, J. A., Zeldin, D. C., Conte, M. S., & Liao, J. K. (2002) · Circulation Research · doi:10.1161/01.res.0000017727.35930.33 · Cited by 171
Smith, K. R., Pinkerton, K. E., Watanabe, T., Pedersen, T. L., Ma, S. J., & Hammock, B. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409591102 · Cited by 170
Self-citationCapra, V., Thompson, M. D., Sala, A., Cole, D. E., Folco, G., & Rovati, G. E. (2007) · Medicinal Research Reviews · doi:10.1002/med.20071 · Cited by 168
Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo
Ai, D., Fu, Y., Guo, D., Tanaka, H., Wang, N., Tang, C., Hammock, B. D., Shyy, J. Y.-J., & Zhu, Y. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703229104 · Cited by 161
Self-citationİnceoğlu, B., Jinks, S. L., Schmelzer, K. R., Waite, T., Kim, I.-H., & Hammock, B. D. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.07.031 · Cited by 156
Self-citationPotente, M., Fißlthaler, B., Busse, R., & Fleming, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305385200 · Cited by 155
Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy
Ai, D., Pang, W., Li, N., Xu, M., Jones, P. D., Yang, J., Zhang, Y., Chiamvimonvat, N., Shyy, J. Y.-J., Hammock, B. D., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811022106 · Cited by 155
Self-citationCytochrome P-450-dependent oxygenation of arachidonic acid to hydroxyicosatetraenoic acids.
Capdevila, J. H., Marnett, L. J., Chacos, N., Prough, R. A., & Estabrook, R. W. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.3.767 · Cited by 154
Fornage, M., Boerwinkle, E., Doris, P. A., Jacobs, D. R., Liu, K., & Wong, N. D. (2004) · Circulation · doi:10.1161/01.cir.0000109487.46725.02 · Cited by 150
Novel epoxides formed during the liver cytochrome P-450 oxidation of arachidonic acid
Chacos, N., Falck, J. R., Martinwixtrom, C. A., & Capdevila, J. H. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)91336-5 · Cited by 149
Compensatory Mechanism for Homeostatic Blood Pressure Regulation in Ephx2 Gene-disrupted Mice
Luria, A., Weldon, S. M., Kabcenell, A. K., Ingraham, R. H., Matera, D., Jiang, H., Gill, R., Morisseau, C. H. P., Newman, J. W. I., & Hammock, B. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608057200 · Cited by 145
Self-citationHigh Vascular Pressure–Induced Lung Injury Requires P450 Epoxygenase–Dependent Activation of TRPV4
Jian, M., KING, J. A. C., Al‐Mehdi, A., Liedtke, W., & Townsley, M. I. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0192oc · Cited by 139
Manhiani, M. M., Quigley, J. E., Knight, S. F., Tasoobshirazi, S., Moore, T., Brands, M. W., Hammock, B. D., & Imig, J. D. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00098.2009 · Cited by 137
Self-citationKoerner, I. P., Jacks, R., DeBarber, A. E., Koop, D. R., Mao, P., Grant, D. F., & Alkayed, N. J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0056-07.2007 · Cited by 135
Krötz, F., Riexinger, T., Buerkle, M. A., Nithipatikom, K., GLOE, T. R., Sohn, H., Campbell, W. B., & Pohl, U. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000116219.09040.8c · Cited by 134
Epoxyeicosatrienoic acids, cell signaling and angiogenesis
Fleming, I. (2006) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.05.003 · Cited by 132
An essential role for SRC-activated STAT-3 in 14,15-EET–induced VEGF expression and angiogenesis
Cheranov, S. Y., Karpurapu, M., Wang, D., Zhang, B., Venema, R. C., & Rao, G. N. (2008) · Blood · doi:10.1182/blood-2007-11-126680 · Cited by 131
Dorrance, A. M., Rupp, N., Pollock, D. M., Newman, J. W. I., Hammock, B. D., & Imig, J. D. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000189600.74157.6d · Cited by 130
Self-citationMichaelis, U. R., & Fleming, I. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.003 · Cited by 127
Ulu, A., Davis, B. B., Tsai, H.-J., Kim, I.-H., Morisseau, C. H. P., İnceoğlu, B., Fiehn, O., Hammock, B. D., & Weiss, R. H. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318185fa3c · Cited by 124
Self-citationElmarakby, A. A., Quigley, J. E., Pollock, D. M., & Imig, J. D. (2006) · Hypertension · doi:10.1161/01.hyp.0000198545.01860.90 · Cited by 121
Self-citationInhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation
Davis, B. B., Thompson, D. A., Howard, L. L., Morisseau, C. H. P., Hammock, B. D., & Weiss, R. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261710799 · Cited by 120
Self-citationKeserü, B., Barbosa‐Sicard, E., Popp, R., Fißlthaler, B., Dietrich, A., Gudermann, T. W., Hammock, B. D., Falck, J. R., Weißmann, N., Busse, R., et al. (2008) · The FASEB Journal · doi:10.1096/fj.08-112821 · Cited by 120
Self-citationLi, P., Cai-lian, C., Bortell, R., & Campbell, W. B. (1999) · Circulation Research · doi:10.1161/01.res.85.4.349 · Cited by 117
Pokreisz, P., Fleming, I., Kiss, L., Barbosa‐Sicard, E., Fißlthaler, B., Falck, J. R., Hammock, B. D., Kim, I.-H., Szelid, Z., Vermeersch, P., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000208299.62535.58 · Cited by 117
Self-citationPotente, M., Michaelis, U. R., Fißlthaler, B., Busse, R., & Fleming, I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110806200 · Cited by 114
Simpkins, A. N., Rudic, R. D., Schreihofer, D. A., Roy, S., Manhiani, M. M., Tsai, H.-J., Hammock, B. D., & Imig, J. D. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080544 · Cited by 113
Self-citationChen, C., Li, G., Liao, W., Wu, J., Liu, L., Ma, D., Zhou, J., Elbekai, R. H., Edin, M. L., Zeldin, D. C., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.152017 · Cited by 109
Vascular Cytochrome P450 Enzymes: Physiology and Pathophysiology
Fleming, I. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2007.11.002 · Cited by 103
Liu, M., & Alkayed, N. J. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600085 · Cited by 102
Fornage, M., Lee, C. R., Doris, P. A., Bray, M. S., HEISS, G. M., Zeldin, D. C., & Boerwinkle, E. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi315 · Cited by 102
Motoki, A., Merkel, M. J., Packwood, W. H., Cao, Z., Liu, L., Iliff, J. J., Alkayed, N. J., & Winkle, D. M. V. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00428.2008 · Cited by 101
DREISBACH, A., Japa, S., SIGEL, A., PARENTI, M., HESS, A., Srinouanprachanh, S. L., Rettie, A. E., Kim, H., Farin, F. M., & Hamm, L. L. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.04.019 · Cited by 98
Imig, J. D., Inscho, E. W., Deichmann, P. C., Reddy, K. M., & Falck, J. R. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.408 · Cited by 98
Self-citationMiyata, N., Seki, T., Tanaka, Y., Omura, T., Taniguchi, K., Doi, M., Bandou, K., Kametani, S., Sato, M., Okuyama, S., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.083964 · Cited by 98
Renić, M., Klaus, J. A., Omura, T., et al. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.156 · Cited by 97
Gross, G. J., Gauthier, K. M., Moore, J. M., Falck, J. R., Hammock, B. D., Campbell, W. B., & Nithipatikom, K. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00186.2008 · Cited by 91
Self-citationTerashvili, M., Tseng, L. F., Wu, H.-E., Narayanan, J., Hart, L. M., Falck, J. R., Pratt, P. F., & Harder, D. R. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.136739 · Cited by 90
Cardiovascular Therapeutic Aspects of Soluble Epoxide Hydrolase Inhibitors
Imig, J. D. (2006) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2006.00169.x · Cited by 90
Self-citationEpoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells
Katragadda, D., Batchu, S. N., Cho, W. J., Chaudhary, K. R., Falck, J. R., & Seubert, J. M. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.02.028 · Cited by 90
Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble expoxide hydrolase
Loch, D. C., Hoey, A. J., Morisseau, C. H. P., Hammock, B. D., & Brown, L. (2007) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:47:1:87 · Cited by 87
Self-citationChemokine Receptor 2b Inhibition Provides Renal Protection in Angiotensin II–Salt Hypertension
Elmarakby, A. A., Quigley, J. E., Olearczyk, J. J., Sridhar, A., Cook, A. K., Inscho, E. W., Pollock, D. M., & Imig, J. D. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.098806 · Cited by 84
Self-citationSato, K., Emi, M., Ezura, Y., Fujita, Y., Takada, D., Ishigami, T., Umemura, S., Xin, Y., Wu, L., Larrinaga‐Shum, S., et al. (2003) · Journal of Human Genetics · doi:10.1007/s10038-003-0103-6 · Cited by 83
Olearczyk, J. J., Quigley, J. E., Mitchell, B. C., Yamamoto, T., Kim, I.-H., Newman, J. W. I., Luria, A., Hammock, B. D., & Imig, J. D. (2008) · Clinical Science · doi:10.1042/cs20080039 · Cited by 81
Self-citationWei, Q., Doris, P. A., Pollizotto, M. V., Boerwinkle, E., Jacobs, D. R., Siscovick, D. S., & Fornage, M. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.021 · Cited by 80
Role of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids in hypertension
Sarkis, A., López, B., & Roman, R. J. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200403000-00009 · Cited by 78
EET Displays Anti-Inflammatory Effects in TNF-α–Stimulated Human Bronchi
Morin, C., Sirois, M., Échavé, V., Gomes, M. M., & Rousseau, É. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0232oc · Cited by 72
Fang, X., Hu, S., Watanabe, T., Weintraub, N. L., Snyder, G. D., Yao, J., Liu, Y., Shyy, J. Y.-J., Hammock, B. D., & Spector, A. A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085605 · Cited by 70
Self-citationYan, G., Chen, S., You, B., & Sun, J. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn006 · Cited by 69
Fleming, I. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.08.002 · Cited by 69
Hutchens, M. P., Nakano, T., Dunlap, J. B., Traystman, R. J., Hurn, P. D., & Alkayed, N. J. (2007) · Resuscitation · doi:10.1016/j.resuscitation.2007.06.031 · Cited by 68
Vascular localization of soluble epoxide hydrolase in the human kidney
Yu, Z., Davis, B. B., Morisseau, C. H. P., et al. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00165.2003 · Cited by 66
Polymorphism in Soluble Epoxide Hydrolase and Blood Pressure in Spontaneously Hypertensive Rats
Fornage, M., Hinojos, C. A., Nurowska, B. W., Boerwinkle, E., Hammock, B. D., Morisseau, C. H. P., & Doris, P. A. (2002) · Hypertension · doi:10.1161/01.hyp.0000032278.75806.68 · Cited by 65
Self-citationYang, S., Wei, S., Pozzi, A., & Capdevila, J. H. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.05.006 · Cited by 63
Pulmonary arterial hypertension: current therapeutic strategies
Puri, A., McGoon, M. D., & Kushwaha, S. S. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0890 · Cited by 62
Revermann, M., Barbosa‐Sicard, E., Dony, E., SCHERMULY, R. T., Morisseau, C. H. P., Geißlinger, G., Fleming, I., Hammock, B. D., & Brandes, R. P. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32831aedfa · Cited by 58
Self-citationRole of EETs in regulation of endothelial permeability in rat lung
Alvarez, D. F., Gjerde, E.-A. B., & Townsley, M. I. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00150.2003 · Cited by 54
Gerry Brooks and epoxide hydrolases: four decades to a pharmaceutical
Morisseau, C. H. P., & Hammock, B. D. (2008) · Pest Management Science · doi:10.1002/ps.1583 · Cited by 50
Self-citationThe Cardiovascular Pharmacology of COX-2 Inhibition
Fries, S., & Großer, T. (2005) · Hematology · doi:10.1182/asheducation-2005.1.445 · Cited by 45
Soluble Epoxide Hydrolase, a Target with Multiple Opportunities for Cardiovascular Drug Discovery
Marino, J. P. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609788340805 · Cited by 43
Harris, T. R., Aronov, P. A., Jones, P. D., Tanaka, H., Arand, M., & Hammock, B. D. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.01.016 · Cited by 43
Self-citationGhosh, S., Chiang, P., Wahlstrom, J. L., Fujiwara, H., Selbo, J. G., & Roberds, S. L. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2008.00213.x · Cited by 42
Widstrom, R. L., Norris, A. W., Veer, J. V. D., & Spector, A. A. (2003) · Biochemistry · doi:10.1021/bi034971d · Cited by 42
Medhora, M. M., Dhanasekaran, A., Gruenloh, S. K., Dunn, L. K., Gabrilovich, M. I., Falck, J. R., Harder, D. R., Jacobs, E. R., & Pratt, P. F. (2006) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.05.025 · Cited by 41
Fife, K. L., Liu, Y., Schmelzer, K. R., Tsai, H.-J., Kim, I.-H., Morisseau, C. H. P., Hammock, B. D., & Kroetz, D. L. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.142398 · Cited by 32
Self-citationThiazolidinedione insulin sensitizers and the heart: a tale of two organs?
Buckingham, R. E., & Hanna, A. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00700.x · Cited by 28
Antileukotrienes in the treatment of asthma and allergic rhinitis
Ribeiro, J. D., Toro, A. A. D. C., & Baracat, E. C. E. (2006) · Jornal de Pediatria · doi:10.2223/jped.1553 · Cited by 22
Rat Cytosolic Epoxide Hydrolase
Oesch, F., Schladt, L., Hartmann, R., et al. (1986) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5134-4_16 · Cited by 17
Current Pharmacological Treatment of Pulmonary Arterial Hypertension
Bouros, D. E., Steiropoulos, P., & Trakada, G. (2008) · Current Clinical Pharmacology · doi:10.2174/157488408783329887 · Cited by 17
Harris, T. R., Aronov, P. A., & Hammock, B. D. (2008) · DNA and Cell Biology · doi:10.1089/dna.2008.0751 · Cited by 9
Self-citation
Cited by
Omega-3 Fatty Acids and Cardiovascular Disease
Mozaffarian, D., & Wu, J. H. Y. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.063 · Cited by 1,771
Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets
Wang, B., Wu, L., Chen, J., Dong, L., Chen, C., Wen, Z., Hu, J., Fleming, I., & Wang, D. W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00443-w · Cited by 1,414
Talele, T. T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00472 · Cited by 1,023
The influence of lipophilicity in drug discovery and design
Arnott, J. A., & Planey, S. L. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.714363 · Cited by 868
Meanwell, N. A. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200211v · Cited by 620
Metadata
- Authors
- Imig, J. D., & Hammock, B. D.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2009-10
- Volume
- 8
- Issue
- 10
- Pages
- 794-805
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1983798804
- Cited by
- 614
- References
- 112
- FWCI
- 2.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.